We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
Cap. Flow
+$11.3M
Cap. Flow %
2.61%
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.08M
2
SVC
Service Properties Trust
SVC
+$1.9M
3
PPL
PPL Corp
PPL
+$1.79M
4
CPT icon
Camden Property Trust
CPT
+$1.59M
5
DRE
Duke Realty Corp.
DRE
+$1.53M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.55M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.1M
3
BP icon
BP
BP
+$798K
4
XRX icon
Xerox
XRX
+$774K
5
AZN icon
AstraZeneca
AZN
+$716K

Sector Composition

Rank Sector Weight
1 Financials 15.83%
2 Technology 14.13%
3 Healthcare 12.38%
4 Energy 11.6%
5 Industrials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
326
Autodesk
ADSK
$52.6B
$272K 0.06%
4,828
+329
+7% +$16.7K
FAST icon
327
Fastenal
FAST
$59.5B
$272K 0.06%
21,972
+404
+2% +$5K
AME icon
328
Ametek
AME
$58.2B
$271K 0.06%
5,188
-803
-13% -$42.2K
L icon
329
Loews
L
$23.6B
$271K 0.06%
6,159
+107
+2% +$4.67K
PAYX icon
330
Paychex
PAYX
$42.7B
$271K 0.06%
6,510
+95
+1% +$3.9K
GPC icon
331
Genuine Parts
GPC
$18.7B
$270K 0.06%
3,079
+36
+1% +$3.1K
MAT icon
332
Mattel
MAT
$4.23B
$266K 0.06%
6,825
+79
+1% +$3.07K
ESV
333
DELISTED
Ensco Rowan plc
ESV
$261K 0.06%
1,172
+14
+1% +$2.9K
DVA icon
334
DaVita
DVA
$11.7B
$258K 0.06%
3,570
+65
+2% +$4.52K
NEM icon
335
Newmont
NEM
$119B
$256K 0.06%
10,044
+189
+2% +$4.55K
CF icon
336
CF Industries
CF
$17.3B
$253K 0.06%
5,260
-200
-4% -$9.79K
NRG icon
337
NRG Energy
NRG
$24.8B
$253K 0.06%
6,789
+342
+5% +$11.8K
CAG icon
338
Conagra Brands
CAG
$7.23B
$251K 0.06%
10,884
+176
+2% +$4.26K
XEC
339
DELISTED
CIMAREX ENERGY CO
XEC
$251K 0.06%
+1,749
New +$223K
NI icon
340
NiSource
NI
$20.4B
$249K 0.06%
16,117
+292
+2% +$4.22K
GGP
341
DELISTED
GGP Inc.
GGP
$247K 0.06%
10,499
+181
+2% +$4.2K
FLR icon
342
Fluor
FLR
$7.96B
$245K 0.06%
3,186
+11
+0.3% +$839
NTAP icon
343
NetApp
NTAP
$37.2B
$243K 0.06%
6,650
+103
+2% +$3.69K
TRIP icon
344
TripAdvisor
TRIP
$1.26B
$243K 0.06%
+2,239
New +$206K
KLAC icon
345
KLA
KLAC
$259B
$242K 0.06%
33,250
+190
+0.6% +$1.26K
CLX icon
346
Clorox
CLX
$12.7B
$237K 0.05%
2,589
+10
+0.4% +$896
KSU
347
DELISTED
Kansas City Southern
KSU
$237K 0.05%
2,204
+21
+1% +$2.17K
TAP icon
348
Molson Coors Class B
TAP
$8.09B
$236K 0.05%
+3,184
New +$205K
BBBY
349
DELISTED
Bed Bath & Beyond Inc
BBBY
$235K 0.05%
4,100
-115
-3% -$7.18K
JNPR
350
DELISTED
Juniper Networks
JNPR
$234K 0.05%
9,536
-384
-4% -$9.54K
12 13
14
15 16

Similar funds

BO
Bach Option Wanchai, Hong Kong $236M AUM 21.45% 1-Year Est. Return
GCA
Gideon Capital Advisors New York $291M AUM 28.95% 1-Year Est. Return
QCM
Quadrant Capital Management Fairfield, New Jersey $221M AUM 29.88% 1-Year Est. Return
AEPI
AH Equity Partners I Menlo Park, California $221M AUM
AC
Asturias Capital New York $220M AUM 39.56% 1-Year Est. Return
LA
Lau Associates Greenville, Delaware $201M AUM 26.29% 1-Year Est. Return
JFM
Jackson Financial Management Costa Mesa, California $194M AUM 21.54% 1-Year Est. Return
SHA
Shelter Harbor Advisors Weatogue, Connecticut $192M AUM 26.7% 1-Year Est. Return

ClearArc Capital's Q2 2014 Portfolio in Review

As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
  • ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
  • ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
  • ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
  • ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
  • ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
  • ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.

Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.